 Jennifer Simpson
Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 4 | 2020 | 1021 | 0.710 |
Why?
| | Medical Staff, Hospital | 1 | 2021 | 75 | 0.700 |
Why?
| | Aftercare | 1 | 2020 | 186 | 0.610 |
Why?
| | Ambulatory Care | 1 | 2020 | 478 | 0.530 |
Why?
| | Burnout, Professional | 1 | 2021 | 322 | 0.510 |
Why?
| | Electronic Health Records | 2 | 2021 | 800 | 0.490 |
Why?
| | Patient Readmission | 1 | 2020 | 609 | 0.470 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 975 | 0.450 |
Why?
| | Atrial Fibrillation | 2 | 2012 | 322 | 0.350 |
Why?
| | Inpatients | 2 | 2021 | 380 | 0.280 |
Why?
| | Brain Ischemia | 3 | 2020 | 299 | 0.250 |
Why?
| | Oncology Service, Hospital | 1 | 2021 | 15 | 0.190 |
Why?
| | Inventions | 1 | 2020 | 18 | 0.180 |
Why?
| | Hospitals, University | 1 | 2021 | 172 | 0.180 |
Why?
| | Medical Informatics | 1 | 2021 | 90 | 0.170 |
Why?
| | Efficiency, Organizational | 1 | 2021 | 125 | 0.170 |
Why?
| | Ambulatory Care Facilities | 1 | 2020 | 213 | 0.160 |
Why?
| | Aged, 80 and over | 3 | 2020 | 6344 | 0.130 |
Why?
| | Health Personnel | 1 | 2020 | 574 | 0.120 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1394 | 0.110 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 225 | 0.110 |
Why?
| | Telemetry | 1 | 2012 | 36 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1317 | 0.100 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 544 | 0.100 |
Why?
| | Cohort Studies | 2 | 2020 | 4894 | 0.100 |
Why?
| | Monitoring, Ambulatory | 1 | 2012 | 81 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 2 | 2012 | 811 | 0.100 |
Why?
| | Radioimmunotherapy | 1 | 2011 | 11 | 0.100 |
Why?
| | Colorado | 1 | 2021 | 4099 | 0.090 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4411 | 0.090 |
Why?
| | Whole-Body Irradiation | 1 | 2011 | 73 | 0.090 |
Why?
| | Aged | 4 | 2020 | 19061 | 0.090 |
Why?
| | Transplantation Conditioning | 1 | 2011 | 151 | 0.090 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 98 | 0.090 |
Why?
| | Texas | 1 | 2010 | 188 | 0.090 |
Why?
| | Mexican Americans | 1 | 2010 | 101 | 0.080 |
Why?
| | Sex Factors | 2 | 2012 | 1715 | 0.080 |
Why?
| | Middle Aged | 4 | 2020 | 26719 | 0.080 |
Why?
| | Risk | 1 | 2010 | 812 | 0.070 |
Why?
| | Recurrence | 1 | 2010 | 935 | 0.070 |
Why?
| | Population Surveillance | 1 | 2010 | 392 | 0.070 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2011 | 520 | 0.070 |
Why?
| | Humans | 7 | 2021 | 114623 | 0.060 |
Why?
| | Retrospective Studies | 2 | 2020 | 12542 | 0.060 |
Why?
| | Male | 5 | 2020 | 55554 | 0.060 |
Why?
| | Female | 5 | 2020 | 59466 | 0.060 |
Why?
| | Age Factors | 1 | 2010 | 2894 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2010 | 2537 | 0.050 |
Why?
| | User-Computer Interface | 1 | 2020 | 140 | 0.040 |
Why?
| | Prospective Studies | 1 | 2010 | 6217 | 0.040 |
Why?
| | Risk Factors | 1 | 2010 | 8628 | 0.040 |
Why?
| | Infusions, Intra-Arterial | 1 | 2015 | 46 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 371 | 0.030 |
Why?
| | Clinical Competence | 1 | 2020 | 893 | 0.030 |
Why?
| | Ischemic Attack, Transient | 1 | 2012 | 62 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2015 | 355 | 0.020 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 82 | 0.020 |
Why?
| | Transplantation, Autologous | 1 | 2011 | 176 | 0.020 |
Why?
| | Radiopharmaceuticals | 1 | 2011 | 157 | 0.020 |
Why?
| | Rituximab | 1 | 2011 | 150 | 0.020 |
Why?
| | Salvage Therapy | 1 | 2011 | 127 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6112 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2012 | 279 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 944 | 0.020 |
Why?
| | Stroke Volume | 1 | 2012 | 504 | 0.020 |
Why?
| | Electrocardiography | 1 | 2012 | 560 | 0.020 |
Why?
| | Survival Analysis | 1 | 2012 | 1211 | 0.020 |
Why?
| | Anticoagulants | 1 | 2012 | 550 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2011 | 1262 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2279 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3039 | 0.010 |
Why?
| | Adult | 2 | 2012 | 30528 | 0.010 |
Why?
| | Young Adult | 1 | 2011 | 10455 | 0.010 |
Why?
|
|
Simpson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|